Data from EMC - Curated by Toby Galbraith - Last updated 18 May 2017

Licensing authority

EMA (European Medicines Agency)


ZEPATIER is indicated for the treatment of chronic hepatitis C (CHC) in adults.

Full Prescribing information

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.


See information on best practice in solid organ transplantation, and expert discussions on related hot topics.

Visit Transplantation


Learn about the complex factors influencing development of obesity

Visit Obesity

Related Content

More information

Category Value
Agency product number EMEA/H/C/004126
Orphan designation No
Date First Approved 22-07-2016
Type Medicinal product subject to restricted medical prescription
Marketing authorisation holder Merck Sharp & Dohme Limited